[Status of plasma blood clotting factors during different stages of erythromyelosis in rats and the effect of hexaphosphamide on the indices studied].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001388:Aziridines / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D001779:Blood Coagulation Factors / Q000032:analysis*; D004915:Leukemia, Erythroblastic, Acute / Q000097:blood / Q000188:drug therapy*; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D051381:Rats
D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D001779:Blood Coagulation Factors; D009946:Organothiophosphorus Compounds; C013556:hexaphosphamide
Sostoianie plazmennykh faktorov svertyvaiushcheĭ sistemy krovi v dinamike éritromieloza krys i vliianie geksafosfamida na izuchaemye pokazateli.